Clinical Trial Update: Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on fecal microbiota transplantation for Carbapenem-resistant Enterobacteriaceae infection (phase 2/3), with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Enterobacteriaceae Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Carbapenem-Resistant Enterobacteriaceae Infection | Phase 2, Phase 3 | Status: COMPLETED